Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Miyamoto S, Guzman RC, Osborn RC, Nandi S. Neoplastic transformation of mouse mammary epithelial cells by in vitro exposure to N-methyl-N-nitrosourea. Proc Natl Acad Sci U S A. 1988 Jan;85(2):477-81. doi: 10.1073/pnas.85.2.477. PubMed PMID: 3422439; PubMed Central PMCID: PMC279573.
Miyamoto S, Sukumar S, Guzman RC, Osborn RC, Nandi S. Transforming c-Ki-ras mutation is a preneoplastic event in mouse mammary carcinogenesis induced in vitro by N-methyl-N-nitrosourea. Mol Cell Biol. 1990 Apr;10(4):1593-9. doi: 10.1128/mcb.10.4.1593-1599.1990. PubMed PMID: 2181280; PubMed Central PMCID: PMC362264.
Miyamoto S, Guzman RC, Shiurba RA, Firestone GL, Nandi S. Transfection of activated Ha-ras protooncogenes causes mouse mammary hyperplasia. Cancer Res. 1990 Sep 15;50(18):6010-4. PubMed PMID: 2203525.
Guzman RC, Osborn RC, Swanson SM, Sakthivel R, Hwang SI, Miyamoto S, Nandi S. Incidence of c-Ki-ras activation in N-methyl-N-nitrosourea-induced mammary carcinomas in pituitary-isografted mice. Cancer Res. 1992 Oct 15;52(20):5732-7. PubMed PMID: 1394197.
Chiao PJ, Miyamoto S, Verma IM. Autoregulation of I kappa B alpha activity. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):28-32. doi: 10.1073/pnas.91.1.28. PubMed PMID: 8278379; PubMed Central PMCID: PMC42879.
Miyamoto S, Chiao PJ, Verma IM. Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines. Mol Cell Biol. 1994 May;14(5):3276-82. doi: 10.1128/mcb.14.5.3276-3282.1994. PubMed PMID: 8164680; PubMed Central PMCID: PMC358694.
Miyamoto S, Schmitt MJ, Verma IM. Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation. Proc Natl Acad Sci U S A. 1994 May 24;91(11):5056-60. doi: 10.1073/pnas.91.11.5056. PubMed PMID: 8197184; PubMed Central PMCID: PMC43930.
Swanson SM, Guzman RC, Christov K, Miyamoto S, Nandi S. Pituitary-isografted mice are highly susceptible to MNU-induced mammary carcinogenesis irrespective of the level of alveolar differentiation. Carcinogenesis. 1994 Jul;15(7):1341-6. doi: 10.1093/carcin/15.7.1341. PubMed PMID: 8033309.
Bera TK, Guzman RC, Miyamoto S, Panda DK, Sasaki M, Hanyu K, Enami J, Nandi S. Identification of a mammary transforming gene (MAT1) associated with mouse mammary carcinogenesis. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9789-93. doi: 10.1073/pnas.91.21.9789. PubMed PMID: 7937892; PubMed Central PMCID: PMC44902.
Miyamoto S, Maki M, Schmitt MJ, Hatanaka M, Verma IM. Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12740-4. doi: 10.1073/pnas.91.26.12740. PubMed PMID: 7809113; PubMed Central PMCID: PMC45515.
Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 1995 Nov 15;9(22):2723-35. doi: 10.1101/gad.9.22.2723. Review. PubMed PMID: 7590248.
Miyamoto S, Cauley K, Verma IM. Ultraviolet cross-linking of DNA binding proteins. Methods Enzymol. 1995;254:632-41. doi: 10.1016/0076-6879(95)54045-8. PubMed PMID: 8531720.
Miyamoto S, Verma IM. Rel/NF-kappa B/I kappa B story. Adv Cancer Res. 1995;66:255-92. Review. PubMed PMID: 7793317.
Miyamoto S, Seufzer BJ, Shumway SD. Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells. Mol Cell Biol. 1998 Jan;18(1):19-29. doi: 10.1128/MCB.18.1.19. PubMed PMID: 9418849; PubMed Central PMCID: PMC121444.
Satomi Y, Miyamoto S, Gould MN. Induction of AP-1 activity by perillyl alcohol in breast cancer cells. Carcinogenesis. 1999 Oct;20(10):1957-61. doi: 10.1093/carcin/20.10.1957. PubMed PMID: 10506111.
Shumway SD, Maki M, Miyamoto S. The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain. J Biol Chem. 1999 Oct 22;274(43):30874-81. doi: 10.1074/jbc.274.43.30874. PubMed PMID: 10521480.
Zhang Y, Sun X, Muraoka K, Ikeda A, Miyamoto S, Shimizu H, Yoshioka K, Yamamoto K. Immunosuppressant FK506 activates NF-kappaB through the proteasome-mediated degradation of IkappaBalpha. Requirement for Ikappabalpha n-terminal phosphorylation but not ubiquitination sites. J Biol Chem. 1999 Dec 3;274(49):34657-62. doi: 10.1074/jbc.274.49.34657. PubMed PMID: 10574930.
Yang CR, Wilson-Van Patten C, Planchon SM, Wuerzberger-Davis SM, Davis TW, Cuthill S, Miyamoto S, Boothman DA. Coordinate modulation of Sp1, NF-kappa B, and p53 in confluent human malignant melanoma cells after ionizing radiation. FASEB J. 2000 Feb;14(2):379-90. doi: 10.1096/fasebj.14.2.379. PubMed PMID: 10657994.
Huang TT, Kudo N, Yoshida M, Miyamoto S. A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1014-9. doi: 10.1073/pnas.97.3.1014. PubMed PMID: 10655476; PubMed Central PMCID: PMC15505.
Narayanan K, Balakrishnan A, Miyamoto S. NF-kappaB is essential for induction of pro-inflammatory cytokine genes by filarial parasitic sheath proteins. Mol Immunol. 2000 Feb-Mar;37(3-4):115-23. doi: 10.1016/s0161-5890(00)00039-0. PubMed PMID: 10865110.
Huang TT, Wuerzberger-Davis SM, Seufzer BJ, Shumway SD, Kurama T, Boothman DA, Miyamoto S. NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events. J Biol Chem. 2000 Mar 31;275(13):9501-9. doi: 10.1074/jbc.275.13.9501. PubMed PMID: 10734098.
Fields ER, Seufzer BJ, Oltz EM, Miyamoto S. A switch in distinct I kappa B alpha degradation mechanisms mediates constitutive NF-kappa B activation in mature B cells. J Immunol. 2000 May 1;164(9):4762-7. doi: 10.4049/jimmunol.164.9.4762. PubMed PMID: 10779782.
Krishnamoorthy B, Narayanan K, Miyamoto S, Balakrishnan A. Epithelial cells release proinflammatory cytokines and undergo c-Myc-induced apoptosis on exposure to filarial parasitic sheath protein-Bcl2 mediates rescue by activating c-H-Ras. In Vitro Cell Dev Biol Anim. 2000 Sep;36(8):532-8. doi: 10.1290/1071-2690(2000)036<0532:ECRPCA>2.0.CO;2. PubMed PMID: 11149753.
Doucas V, Shi Y, Miyamoto S, West A, Verma I, Evans RM. Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):11893-8. doi: 10.1073/pnas.220413297. PubMed PMID: 11027313; PubMed Central PMCID: PMC17265.
Miyamoto S, Huang TT, Wuerzberger-Davis S, Bornmann WG, Pink JJ, Tagliarino C, Kinsella TJ, Boothman DA. Cellular and molecular responses to topoisomerase I poisons. Exploiting synergy for improved radiotherapy. Ann N Y Acad Sci. 2000;922:274-92. doi: 10.1111/j.1749-6632.2000.tb07045.x. PubMed PMID: 11193903.
Huang TT, Miyamoto S. Postrepression activation of NF-kappaB requires the amino-terminal nuclear export signal specific to IkappaBalpha. Mol Cell Biol. 2001 Jul;21(14):4737-47. doi: 10.1128/MCB.21.14.4737-4747.2001. PubMed PMID: 11416149; PubMed Central PMCID: PMC87155.
Shumway SD, Berchtold CM, Gould MN, Miyamoto S. Evidence for unique calmodulin-dependent nuclear factor-kappaB regulation in WEHI-231 B cells. Mol Pharmacol. 2002 Jan;61(1):177-85. doi: 10.1124/mol.61.1.177. PubMed PMID: 11752219.
Huang TT, Feinberg SL, Suryanarayanan S, Miyamoto S. The zinc finger domain of NEMO is selectively required for NF-kappa B activation by UV radiation and topoisomerase inhibitors. Mol Cell Biol. 2002 Aug;22(16):5813-25. doi: 10.1128/MCB.22.16.5813-5825.2002. PubMed PMID: 12138192; PubMed Central PMCID: PMC133970.
Narayanan K, Seufzer BJ, Brockman-Schneider RA, Gern JE, Balakrishnan A, Miyamoto S. CD14-dependent activation of NF-kappaB by filarial parasitic sheath proteins. Cell Biol Int. 2002;26(1):43-54. doi: 10.1006/cbir.2001.0828. PubMed PMID: 11779220.
Criswell T, Leskov K, Miyamoto S, Luo G, Boothman DA. Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene. 2003 Sep 1;22(37):5813-27. doi: 10.1038/sj.onc.1206680. Review. PubMed PMID: 12947388.
Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell. 2003 Nov 26;115(5):565-76. doi: 10.1016/s0092-8674(03)00895-x. PubMed PMID: 14651848.
Miyamoto S. RelA life and death decisions. Mol Cell. 2004 Mar 26;13(6):763-4. doi: 10.1016/s1097-2765(04)00158-3. PubMed PMID: 15053867.
Shumway SD, Miyamoto S. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells. Biochem J. 2004 May 15;380(Pt 1):173-80. doi: 10.1042/BJ20031796. PubMed PMID: 14763901; PubMed Central PMCID: PMC1224141.
O'Connor S, Shumway SD, Amanna IJ, Hayes CE, Miyamoto S. Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells. Mol Cell Biol. 2004 Jun;24(11):4895-908. doi: 10.1128/MCB.24.11.4895-4908.2004. PubMed PMID: 15143182; PubMed Central PMCID: PMC416427.
Bates PW, Miyamoto S. Expanded nuclear roles for IkappaBs. Sci STKE. 2004 Oct 12;2004(254):pe48. doi: 10.1126/stke.2542004pe48. Review. PubMed PMID: 15479861.
O'Connor S, Shumway S, Miyamoto S. Inhibition of IkappaBalpha nuclear export as an approach to abrogate nuclear factor-kappaB-dependent cancer cell survival. Mol Cancer Res. 2005 Jan;3(1):42-9. PubMed PMID: 15671248.
O'Connor S, Markovina S, Miyamoto S. Evidence for a phosphorylation-independent role for Ser 32 and 36 in proteasome inhibitor-resistant (PIR) IkappaBalpha degradation in B cells. Exp Cell Res. 2005 Jul 1;307(1):15-25. doi: 10.1016/j.yexcr.2005.02.015. Epub 2005 Mar 29. PubMed PMID: 15922723.
Wuerzberger-Davis SM, Chang PY, Berchtold C, Miyamoto S. Enhanced G2-M arrest by nuclear factor-{kappa}B-dependent p21waf1/cip1 induction. Mol Cancer Res. 2005 Jun;3(6):345-53. doi: 10.1158/1541-7786.MCR-05-0028. PubMed PMID: 15972853.
Berchtold CM, Chen KS, Miyamoto S, Gould MN. Perillyl alcohol inhibits a calcium-dependent constitutive nuclear factor-kappaB pathway. Cancer Res. 2005 Sep 15;65(18):8558-66. doi: 10.1158/0008-5472.CAN-04-4072. PubMed PMID: 16166337.
Wu ZH, Mabb A, Miyamoto S. PIDD: a switch hitter. Cell. 2005 Dec 16;123(6):980-2. doi: 10.1016/j.cell.2005.11.025. PubMed PMID: 16360026.
Chang PY, Miyamoto S. Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells. Mol Cancer Res. 2006 Feb;4(2):101-12. doi: 10.1158/1541-7786.MCR-05-0259. PubMed PMID: 16513841.
Wu ZH, Shi Y, Tibbetts RS, Miyamoto S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science. 2006 Feb 24;311(5764):1141-6. doi: 10.1126/science.1121513. PubMed PMID: 16497931.
Chang PY, Draheim K, Kelliher MA, Miyamoto S. NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cells. Cancer Res. 2006 Jun 15;66(12):6008-13. doi: 10.1158/0008-5472.CAN-06-0194. PubMed PMID: 16778171; NIHMSID:NIHMS375227.
Wuerzberger-Davis SM, Nakamura Y, Seufzer BJ, Miyamoto S. NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage. Oncogene. 2007 Feb 1;26(5):641-51. doi: 10.1038/sj.onc.1209815. Epub 2006 Jul 24. PubMed PMID: 16862178.
Mabb AM, Wuerzberger-Davis SM, Miyamoto S. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat Cell Biol. 2006 Sep;8(9):986-93. doi: 10.1038/ncb1458. Epub 2006 Aug 13. PubMed PMID: 16906147.
Berchtold CM, Wu ZH, Huang TT, Miyamoto S. Calcium-dependent regulation of NEMO nuclear export in response to genotoxic stimuli. Mol Cell Biol. 2007 Jan;27(2):497-509. doi: 10.1128/MCB.01772-06. Epub 2006 Oct 30. PubMed PMID: 17074802; PubMed Central PMCID: PMC1800799.
Wu ZH, Miyamoto S. Many faces of NF-kappaB signaling induced by genotoxic stress. J Mol Med (Berl). 2007 Nov;85(11):1187-202. doi: 10.1007/s00109-007-0227-9. Epub 2007 Jul 3. Review. PubMed PMID: 17607554.
Mabb AM, Miyamoto S. SUMO and NF-kappaB ties. Cell Mol Life Sci. 2007 Aug;64(15):1979-96. doi: 10.1007/s00018-007-7005-2. Review. PubMed PMID: 17530464; PubMed Central PMCID: PMC11136396.
Simonson SJS, Wu ZH, Miyamoto S. CYLD: a DUB with many talents. Dev Cell. 2007 Nov;13(5):601-603. doi: 10.1016/j.devcel.2007.10.009. PubMed PMID: 17981127.
Yang DT, Young KH, Kahl BS, Markovina S, Miyamoto S. Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma. Mol Cancer. 2008 May 19;7:40. doi: 10.1186/1476-4598-7-40. PubMed PMID: 18489772; PubMed Central PMCID: PMC2408930.
What would you like to do?